GO
Loading...

Video and TV

More

CAT CEO: Global outlook a mixed bag     Thu, 24 Apr '14 | 8:02 AM ET

Doug Oberhelman, Caterpillar chairman & CEO, digs deep into the company's first quarter results and shares his outlook on global sales. CAT reported EPS of $1.44 on revenues of $13.24 billion, beating on both the top and bottom line.

I think this is going to be the corporate story of the year, says Austan Goolsbee, 32 Advisors strategic partner, discussing how the tech giant is likely to spend its cash.

Mad Money host Jim Cramer says shareholder activism works for every shareholder, and offers his take on the Valeant/Bill Ackman bid to acquire Allergan. The market is better off for these efforts, he says.

Discussing Apple's 7-for-1 stock split effective June 9, and the company's bad tablet number, with Max Wolff, Citizen VC chief economist, and Gene Munster, Piper Jaffray senior research analyst.

CNBC's Becky Quick speaks with Warren Buffett about why he abstained in his vote on Coke shareholder equity plan. The package was excessive, he says.

Carl Icahn's take on Ackman & Valeant     Wed, 23 Apr '14 | 9:19 AM ET

Activist investor Carl Icahn comments on Bill Ackman's role in the Valeant Pharmaceuticals bid for Allergan. The "Squawk on the Street" team provide insight.

Cramer: Can't lose if you're Ackman     Wed, 23 Apr '14 | 9:17 AM ET

The "Squawk on the Street" news team discuss the involvement of Bill Ackman in the deal between Valeant Pharmaceuticals and Allergan.

William Ackman, Pershing Square Capital Management, explains how his partnership with Valeant is structured. And J. Michael Pearson, Valeant chairman & CEO, discusses why he partnered with Ackman instead of pursing Allergan alone. Creating shareholder value is our job, says Pearson.

It's not a dirty little secret anymore, says Heather Thomson, Yummie by Heather Thomson founder, discussing how her company is redefining the shapewear industry and carving out a piece of the market.

Who will win Aereo case?     Tue, 22 Apr '14 | 1:19 PM ET

Porter Bibb, MediaTech Capital Partners, shares his thoughts on the likely outcome of the Aereo case and who will be the winners and losers.

How to play big pharma     Tue, 22 Apr '14 | 1:10 PM ET

Barbara Ryan, CNBC contributor, shares an inside look at what's happening among the drug giants as billion dollar deals are announced and big player reshape the industry.

Gasoline hits 8-month high     Tue, 22 Apr '14 | 12:33 PM ET

The Futures Now team discusses what's likely driving the increase in gasoline prices.

Meb Keflezighi, the first American man to win the Boston Marathon since 1983, explains what ended his sneaker deal with Nike three years ago.

CNBC's Mary Thompson and Art Cashin, of UBS, discuss the S&P 500 nearing its next resistance level, and the potential it breaks through to an all-time high.

CNBC's David Faber speaks with activist investor Ralph Whitworth, Relational Investors founder and principal, about his relationship with the management team at Mondelez and the opportunity he sees in SPX Corp.

Tesla delivers Model S to China     Tue, 22 Apr '14 | 11:24 AM ET

The Tesla Model S is now available in China. CNBC's Phil LeBeau expects sales for the electric car to ramp up very quickly.

Mossberg on Apple's 'movie studio' model     Tue, 22 Apr '14 | 11:16 AM ET

Walter Mossberg, Re/Code co-executive editor, breaks down Apple's product cycle and compares the tech giant's reprocessing of products to a movie studio.

Beijing Auto Show     Tue, 22 Apr '14 | 11:00 AM ET

American automakers are investing heavily in China, the world's fastest growing car market.

Cramer's favorite marijuana stock     Tue, 22 Apr '14 | 9:55 AM ET

CNBC's Jim Cramer explains why he is watching cannabis stock GW Pharma.

Close look at Allergan bid     Tue, 22 Apr '14 | 9:01 AM ET

The "Squawk on the Street" news team discuss the legality of activist investor Bill Ackman backing the bid of Valeant Pharmaceuticals to acquire Allergan.

USDA: Chances of El Nino now 50-67%     Tue, 22 Apr '14 | 8:42 AM ET

CNBC's Jane Wells reports on the good and bad of El Nino if it develops near South American mines, and coffee and cocoa.

Five generations after it was founded, Leinenkugel Brewing Company is still run by the family and trying to help those who just can't pronounce the name.

Ackman & Valeant's bid for Allergan     Tue, 22 Apr '14 | 7:04 AM ET

In an SEC Filing, Valeant Pharmaceuticals said it expected to offer a mix of stock and about $15 billion in cash for botox maker Allergan. David Krempa, Morningstar equity analyst, and CNBC's Meg Tirrell, provide perspective.

Banking on new digital media     Mon, 21 Apr '14 | 8:37 AM ET

Fred Davis, Arista Advisors CEO, discusses his plans to finance tech startups in Silicon Valley.

Boris Schlossberg, BK Asset Management; Ed Keon, Quantitative Management Associates; and Krishna Guha, ISI Group, discuss the strong euro, the play on the Japanese yen and whether the markets are fairly valued.

Rebecca Patterson, Bessemer Trust, and Barbara Reinhard, Credit Suisse, share their thoughts on the pullback in stocks and the market's reaction to comments made by the Fed's Yellen.

Keystone limbo causes concern     Mon, 21 Apr '14 | 6:08 AM ET

The government's delay of the 1,700 mile Keystone XL pipeline has some lawmakers focused on possible political fallout, reports CNBC's John Harwood.

Trading the whipsaw ride     Thu, 17 Apr '14 | 5:00 PM ET

The voice of CNBC, Jim Birdsall, introduces the "Fast Money" traders before they discuss current market volatility on the 25th anniversary of CNBC. Tim Seymour says this week was all about macro data in the U.S.

The three major indexes closed mixed despite better-than-expected jobless claims this morning. Weak earnings and uncertain news out of Ukraine kept markets in a seesaw. Still, the S&P 500 had its best week since July.

The Week Ahead: Boston Marathon week     Thu, 17 Apr '14 | 4:02 PM ET

CNBC's Tyler Mathisen looks ahead to what are likely to be the week's top business and financial stories. Starbucks and Netflix earnings may have been helped by the bad winter. Also, the Boston Marathon kicks off Monday, and 36,000 runners will participate.

Contact Video and TV

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

U.S. Video

Asia Video

Europe Video